Interesting article in today’s London Times about a company called Levicept and their new drug called Levi-04 - apparently very effective against OA also potentially disease modifying. They’ve managed to raise about $100m to fund next level trials and hope to have it available on the British NHS within 3 years.
Article is paywalled but you should be able to find it if you hunt around a bit.
research reports and media, page-4383
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.060(29.3%) |
Mkt cap ! $92.81M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 26.5¢ | 21.0¢ | $862.8K | 3.580M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |